Your Digestive Struggles May Be Written in Your DNA.

HLA-DQ2 is part of your immune system’s antigen-presenting machinery. Its job is to grab foreign proteins (like gluten peptides) and show them to your T-cells, essentially saying, “Should we attack this?” In people without celiac disease, your immune system looks at gluten and correctly decides it’s harmless. Your intestinal lining stays intact.

Here’s the problem: roughly 25 to 30 percent of people with European ancestry carry the HLA-DQ2 variant. This variant has a genetic structure that perfectly fits gluten peptides, making it the most common genetic marker of celiac disease susceptibility. But carrying HLA-DQ2 alone doesn’t guarantee celiac disease; it’s a necessary condition, not a sufficient one. Many people have the gene and never develop the condition.

If you carry HLA-DQ2 and your gut reacts to gluten, your immune system is mounting an attack on your intestinal villi (the small fingerlike projections that absorb nutrients). You experience bloating, cramps, diarrhea or constipation, brain fog, and nutrient malabsorption that worsens over time if exposure continues. Even trace amounts trigger a response that can last weeks.

FUT2 produces a fucosyltransferase enzyme that adds specific sugar structures to the lining of your digestive tract. This isn’t just decoration; these sugars act as anchors and food sources for beneficial bacteria. Your microbiome composition is largely determined by whether you’re a “secretor” or “non-secretor.” Secretors produce these sugar structures. Non-secretors don’t.

About 20 percent of the population carries the non-secretor variant. Non-secretors have a dramatically different microbiome composition, with reduced populations of beneficial bacteria and increased susceptibility to certain pathogens like norovirus. This genetic difference cascades through your entire gut ecosystem. You don’t just have different bacteria; you have a fundamentally different microbial environment.

If you’re a non-secretor, you may experience harder-to-treat digestive issues, more frequent food reactions, and impaired B12 absorption (since many beneficial bacteria that help produce B12 can’t colonize your gut effectively). You’re also at higher risk for recurring norovirus infections and may respond less effectively to certain probiotics designed for “typical” microbiomes.

NOD2 is a pattern-recognition receptor inside your intestinal cells. Its job is to detect bacterial cell wall components and signal whether the bacteria are friend or foe. When NOD2 works correctly, your gut immune system tolerates beneficial bacteria and responds to pathogens. It’s a critical immune checkpoint that keeps your microbiome balanced and your intestinal barrier healthy.

Roughly 7 to 10 percent of people with European ancestry carry NOD2 variants (most commonly R702W, G908R, or 1007fs). These variants severely impair the receptor’s ability to recognize commensal bacteria, leaving your gut unable to mount an appropriate immune response. Your immune system loses its ability to distinguish between helpful and harmful bacteria, and your intestinal barrier becomes more permeable.

If you carry a NOD2 variant, you have a significantly elevated risk of Crohn’s disease and IBD. Even if you haven’t developed diagnosed IBD, you likely experience chronic gut inflammation, increased intestinal permeability, stronger reactions to food antigens, and a microbiome that’s harder to balance through diet alone. Symptoms include recurrent cramping, unpredictable diarrhea or constipation, malabsorption, and digestive symptoms that flare unpredictably.

VDR is the vitamin D receptor. It’s not the vitamin D itself, but the lock that vitamin D fits into inside your cells. If your VDR doesn’t function well, your cells can’t use vitamin D effectively, even if your blood levels look normal. Vitamin D is critical for intestinal barrier integrity, immune tolerance in the gut, and T-cell regulation. Without functional VDR signaling, all three fail.

VDR variants are extremely common; roughly 50 percent of the population carries at least one risk allele in one of the major VDR polymorphisms (FokI, BsmI, ApaI). People with unfavorable VDR variants have reduced vitamin D receptor expression, meaning their cells are less responsive to vitamin D signaling, and their intestinal immune system remains in a heightened state of reactivity. Your blood test may show adequate vitamin D levels, but your cells aren’t using it.

If you have a VDR variant, you likely experience heightened food sensitivities, stronger histamine reactions, slower recovery from digestive flares, and a general sense that your gut is “reactive.” You may have tried supplementing vitamin D without symptom improvement because standard doses aren’t sufficient given your genetic receptor inefficiency. Your immune system stays primed, and your intestinal barrier remains compromised despite normal blood work.

MTHFR encodes the methylenetetrahydrofolate reductase enzyme, which converts dietary folate into the active form your cells can use (methylfolate). This enzyme is critical not just for DNA synthesis and cell division, but for repairing damaged intestinal tissue, managing immune responses, and detoxifying inflammatory metabolites. When MTHFR is impaired, your gut can’t repair itself efficiently.

The C677T variant is carried by roughly 40 percent of the population, and the A1298C variant by about 35 percent. Both variants reduce enzyme efficiency; people with two copies (homozygous) have 40 to 70 percent reduced activity. This means your cells are converting dietary folate into usable forms at a fraction of the normal rate. You can eat a perfect diet and still be functionally depleted at the cellular level for the methylated nutrients your gut lining desperately needs.

If you carry an MTHFR variant, you likely experience slow recovery from digestive flares, chronic low-grade inflammation, impaired immune tolerance to foods, and nutrient malabsorption for B vitamins and minerals. You may have been told to take folic acid supplements, which actually makes things worse because folic acid requires MTHFR conversion and accumulates if your enzyme is impaired. Your bloating, food reactions, and sluggish gut repair all trace back to this single broken metabolic step.

TNF encodes tumor necrosis factor-alpha, a signaling molecule that triggers inflammation. In controlled amounts, TNF is protective; it helps your immune system fight infections. But elevated TNF levels increase intestinal permeability, promote pro-inflammatory T-cell responses, and make your intestinal barrier “leaky.” The balance between appropriate and excessive TNF determines whether your gut stays intact or becomes permeable.

Roughly 30 percent of the population carries the -308G>A variant in the TNF promoter region. This variant increases TNF expression, pushing your baseline inflammatory tone higher and making your intestinal barrier more permeable even at rest. You’re not experiencing a flare; you’re simply running hot because your genes make more inflammatory signaling molecules than the population average.

If you carry the TNF-308A allele, you likely experience chronic low-grade symptoms (bloating, cramping, loose stools, or constipation) that persist even when you avoid obvious trigger foods. Your gut is more reactive to minor stressors like alcohol, excess sugar, or dehydration. Recovery from digestive flares takes longer because your baseline inflammation is higher. Standard anti-inflammatory diets help, but they’re often insufficient without addressing the genetic upregulation of TNF itself.